Redcare Pharmacy (RDC) Price & Analysis

Compare

60 Followers

RDC Stock Chart & Stats

€65.70

€4.70(3.90%)

At close: Jan 09 4:00 PM EST

€65.70

€4.70(3.90%)

Day’s Range― - ―

52-Week Range€59.45 - €144.40

Previous CloseN/A

Volume73.26K

Average Volume (3M)132.76K

Market Cap

€1.35B

Enterprise Value€2.05B

Total Cash (Recent Filing)€271.29M

Total Debt (Recent Filing)€392.40M

Price to Earnings (P/E)―

Beta0.87

Next Earnings

Mar 04, 2026

EPS Estimate

-0.5

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.33

Shares Outstanding20,578,390

10 Day Avg. Volume128,637

30 Day Avg. Volume132,758

Financial Highlights & Ratios

PEG Ratio-0.22

Price to Book (P/B)5.46

Price to Sales (P/S)1.11

P/FCF Ratio197.36

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€142.51

Price Target Upside116.91% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering7

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Prescription Medicines GrowthStrong acceleration in the German prescription medicines business enabled the company to meet sales targets despite market headwinds, signaling durable demand in the core Rx portfolio.

Profitability And MarginsAn adjusted EBITDA margin that sits within the company's target corridor suggests improving cost discipline and supports expectations for expanding profitability.

Rx Revenue MomentumExpected Rx revenue acceleration to over €150m in Q4 could materially boost top-line momentum and reinforce investor confidence in growth prospects.

Bears Say

Non-prescription Segment WeaknessWeaker-than-expected growth in the non-prescription segment exposes reliance on the prescription business and could limit overall revenue upside.

Share Price Decline And Investor ConfidenceA significant drop in the stock's market value has eroded investor confidence and may lead to increased selling pressure or reduced analyst coverage.

Redcare Pharmacy News

Positive Financial Performance and Growth Prospects Justify Buy Rating for Redcare Pharmacy

Jefferies analyst Martin Comtesse maintained a Buy rating on Redcare Pharmacy today and set a price target of...

2M ago

Redcare Pharmacy’s Rebound: Analyst Recommends Buy Amidst Sales Recovery and Strong Future Outlook

Martin Comtesse, an analyst from Jefferies, maintained the Buy rating on Redcare Pharmacy. The associated price target remains...

3M ago

Optimistic Buy Rating for Redcare Pharmacy Driven by Market Expansion and Strategic Digital Transformation

Redcare Pharmacy, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Martin Comtesse from...

4M ago

Redcare Pharmacy: Strong Financial Performance and Positive Outlook Justify Buy Rating

Jefferies analyst Martin Comtesse maintained a Buy rating on Redcare Pharmacy today and set a price target of...

6M ago

0RJT Earnings this Week: How Will it Perform?

Redcare Pharmacy (0RJT) is scheduled to report 2nd quarter earnings on 07/29/2025. Regarding Q2 estimates, Wall Street analysts...

6M ago

Redcare Pharmacy: Stable Performance and Growth Potential Amidst Temporary Challenges

Analyst Martin Comtesse from Jefferies maintained a Buy rating on Redcare Pharmacy and keeping the price target at...

6M ago

0RJT Upcoming Earnings Report: What to Expect?

Redcare Pharmacy (0RJT) is scheduled to report 1st quarter earnings on 05/06/2025. Regarding Q1 estimates, Wall Street analysts...

8M ago

Strong Customer Growth and Margin Improvement Justify Buy Rating for Redcare Pharmacy

Stifel Nicolaus analyst Yannik Siering maintained a Buy rating on Redcare Pharmacy (0RJT – Research Report) today and...

9M ago

Redcare Pharmacy’s Strong Growth and Strategic Positioning Justify Buy Rating

Yannik Siering, an analyst from Stifel Nicolaus, maintained the Buy rating on Redcare Pharmacy (0RJT – Research Report)....

10M ago

Redcare Pharmacy’s Strong Revenue Growth and Positive 2025 Outlook Reinforce Buy Rating

Martin Comtesse, an analyst from Jefferies, maintained the Buy rating on Redcare Pharmacy (0RJT – Research Report). The...

10M ago

RDC FAQ

What was Redcare Pharmacy’s price range in the past 12 months?

Redcare Pharmacy lowest stock price was €59.45 and its highest was €144.40 in the past 12 months.

What is Redcare Pharmacy’s market cap?

Redcare Pharmacy’s market cap is €1.35B.

When is Redcare Pharmacy’s upcoming earnings report date?

Redcare Pharmacy’s upcoming earnings report date is Mar 04, 2026 which is in 52 days.

How were Redcare Pharmacy’s earnings last quarter?

Redcare Pharmacy released its earnings results on Oct 29, 2025. The company reported -€0.334 earnings per share for the quarter, missing the consensus estimate of -€0.316 by -€0.018.

Is Redcare Pharmacy overvalued?

According to Wall Street analysts Redcare Pharmacy’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Redcare Pharmacy pay dividends?

Redcare Pharmacy does not currently pay dividends.

What is Redcare Pharmacy’s EPS estimate?

Redcare Pharmacy’s EPS estimate is -0.5.

How many shares outstanding does Redcare Pharmacy have?

Redcare Pharmacy has 20,578,390 shares outstanding.

What happened to Redcare Pharmacy’s price movement after its last earnings report?

Redcare Pharmacy reported an EPS of -€0.334 in its last earnings report, missing expectations of -€0.316. Following the earnings report the stock price went down -3.299%.

Which hedge fund is a major shareholder of Redcare Pharmacy?

Currently, no hedge funds are holding shares in DE:RDC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Redcare Pharmacy Stock Smart Score

Neutral

Fundamentals

Return on Equity

-6.98%

Trailing 12-Months

Asset Growth

21.15%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Redcare Pharmacy

Redcare Pharmacy NV owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.

Redcare Pharmacy (RDC) Earnings & Revenues

Historic Earnings Reports

RDC Stock 12 Month Forecast

Average Price Target

€142.51

▲(116.91% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"62":"€62","215":"€215","100.25":"€100.3","138.5":"€138.5","176.75":"€176.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":214,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€214.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":142.51,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€142.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":63.60328046,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€63.60</span>\n  </div></div>","useHTML":true}}],"tickPositions":[62,100.25,138.5,176.75,215],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.1,76.55384615384615,88.00769230769231,99.46153846153845,110.91538461538461,122.36923076923077,133.8230769230769,145.27692307692308,156.73076923076923,168.18461538461537,179.63846153846154,191.09230769230768,202.54615384615383,{"y":214,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.1,71.05461538461537,77.00923076923077,82.96384615384615,88.91846153846153,94.87307692307692,100.8276923076923,106.78230769230768,112.73692307692306,118.69153846153846,124.64615384615384,130.60076923076923,136.5553846153846,{"y":142.51,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.1,64.9848677276923,64.86973545538461,64.75460318307692,64.63947091076923,64.52433863846153,64.40920636615384,64.29407409384615,64.17894182153846,64.06380954923077,63.94867727692308,63.83354500461538,63.71841273230769,{"y":63.60328046,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":131.7,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.5,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116.9,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":122.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.4,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.25,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.75,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.05,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.7,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >